KIF22 Promotes Development of Pancreatic Cancer by Regulating the MEK/ERK/P21 Signaling Axis

Figure 2

The proliferation ability of pancreatic cancer cells was reduced by silenced KIF22 in PANC-1 and MIA PaCa-2. (a) Effective knockdown of KIF22 expression in cells could be achieved via SiRNA2. (b) Silencing KIF22 reduces the proliferation rate of pancreatic cancer cells via MTT assay. (c) Silencing KIF22 reduces the colony forming ability of pancreatic cancer cells by the colony forming assay.

(a)

(b)

(c)